Incidence and risk factors of iron deficiency anemia in term infants

Supapan Tantracheewathorn1, Sirin Lohajaroensub

  • 1Department of Pediatrics, BMA Medical College and Vajira Hospital, 681 Samsen Rd, Dusit, Bangkok 10300, Thailand. supapantan@hotmail.com

Insights

Iron deficiency anemia (IDA) is more common in breast-fed infants than formula-fed infants. Key risk factors for IDA include low birth weight, breastfeeding, and insufficient complementary foods.

Area of Science:

  • Pediatrics
  • Nutritional Science
  • Hematology

Background:

  • Iron deficiency anemia (IDA) is a significant global health concern in infants.
  • Breastfeeding is widely recommended, but concerns exist regarding iron sufficiency.
  • Formula-fed infants typically receive iron-fortified formulas.

Purpose of the Study:

  • To compare the incidence of IDA in breast-fed (BF) versus formula-fed (FF) infants.
  • To identify specific risk factors contributing to IDA in infants.

Main Methods:

  • A cohort study involving 140 full-term infants (70 BF, 70 FF).
  • Infants were monitored from birth to 12 months for growth and development.
  • Hemoglobin, hematocrit, and mean corpuscular volume analyzed at 9-12 months; IDA investigated if hemoglobin < 11.0 g/dl.

Main Results:

  • Breast-fed infants showed significantly lower mean hemoglobin, hematocrit, MCV, and serum ferritin levels compared to formula-fed infants.
  • Anemia prevalence was higher in BF infants (38.6%) than FF infants (14.39%).
  • The incidence of IDA was significantly higher in BF infants (25.7%) versus FF infants (2.9%). Risk factors included low birth weight, breastfeeding, and inadequate complementary food.

Conclusions:

  • IDA is more prevalent in breast-fed infants compared to formula-fed infants.
  • Low birth weight, the practice of breastfeeding, and inadequate iron-rich complementary foods are identified risk factors for IDA.
  • Preventive strategies should focus on iron-rich complementary foods and targeted screening for high-risk infants at 9-12 months.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Vitamins01:30

Vitamins

Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced in our...